Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats

Hepatology

Volumn 51, Issue 5, 2010, Pages 1567-1576

  Azzalini, Lorenzo ^a   Ferrer, Elisabet ^a   Ramalho, Leandra N ^b   Moreno, Montserrat ^a   Domínguez, Marlene ^a   Colmenero, Jordi ^a   Peinado, Víctor I ^a   Barber̀a, Joan A ^a   Arroyo, Vicente ^a   Giǹes, Pere ^a   Caballería, Joan ^a   Bataller, Ramón ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROCOLLAGEN; PROTEIN KINASE B; RNA; SMAD2 PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; ENZYME PHOSPHORYLATION; FIBROGENESIS; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HEPATITIS; HISTOLOGY; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; LIVER CELL DAMAGE; LIVER INJURY; LIVER NECROSIS; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING; ZUCKER RAT;

ANIMALS; APOPTOSIS; FATTY LIVER; OBESITY; OXIDATIVE STRESS; RATS; RATS, ZUCKER; SMOKING; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 77951494897     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23516     Document Type: Article

References (42)

1. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China. N Engl J Med 2005;353:1124-1134. (Pubitemid 41317435)
2. Pham TM, Fujino Y, Ide R, Shirane K, Tokui N, Kubo T, et al. Mortality attributable to cigarette smoking in a cohort study in Japan. Eur J Epidemiol 2007;22:599-605. (Pubitemid 47402441)
3. Whitehead TP, Robinson D, Allaway SL. The effects of cigarette smoking and alcohol consumption on serum liver enzyme activities: a dose-related study in men. Ann Clin Biochem 1996;33(Pt 6):530-535. (Pubitemid 26397716)
4. El-Zayadi AR. Heavy smoking and liver. World J Gastroenterol 2006;12:6098-6101.
5. Bataller R. Time to ban smoking in patients with chronic liver diseases. HEPATOLOGY 2006;44:1394-1396. (Pubitemid 44953642)
6. Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. HEPATOLOGY 2001;34:121-125. (Pubitemid 32591491)
7. Hezode C, Lonjon I, Roudot-Thoraval F, Mavier JP, Pawlotsky JM, Zafrani ES, et al. Impact of smoking on histological liver lesions in chronic hepatitis C. Gut 2003;52:126-129. (Pubitemid 36020778)
8. Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, et al. Risk factors and comorbidities in primary biliary cirrhosis: a controlled interview-based study of 1032 patients. HEPATOLOGY 2005;42:1194-1202. (Pubitemid 43112687)
9. Zein CO, Beatty K, Post AB, Logan L, Debanne S, McCullough AJ. Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: a cross validated retrospective assessment. HEPATOLOGY 2006;44:1564-1571. (Pubitemid 44953661)
10. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 2005;42:218-224. (Pubitemid 40143468)
11. Fujita Y, Shibata A, Ogimoto I, Kurozawa Y, Nose T, Yoshimura T, et al. The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br J Cancer 2006;94:737-739. (Pubitemid 43361907)
12. Wild SH, Byrne CD. ABC of obesity. Risk factors for diabetes and coronary heart disease. BMJ 2006;333:1009-1011.
13. Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol 2008;49:608-612.
14. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007;25:883-889.
15. Rafiq N, Bai C, Fang Y, Srishord M, McCullough A, Gramlich T, et al. Long-term follow-up of patients with nonalcoholic fatty liver. Clin Gastroenterol Hepatol 2009;7:234-238.
16. Dixon JB, Bhathal PS, Jonsson JR, Dixon AF, Powell EE, O'Brien PE. Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol 2003;39:967-971.
17. Serfaty L, Lemoine M. Definition and natural history of metabolic steatosis: clinical aspects of NAFLD,NASHand cirrhosis. Diabetes Metab 2008;34(6 Pt 2):634-637.
18. Simani AS, Inoue S, Hogg JC. Penetration of the respiratory epithelium of guinea pigs following exposure to cigarette smoke. Lab Invest 1974;31:75-81.
19. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. HEPATOLOGY 2005;41:1313-1321. (Pubitemid 40770284)
20. Barreiro E, de la Puente B, Minguella J, Corominas JM, Serrano S, Hussain SN, et al. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;171:1116-1124. (Pubitemid 40663723)
21. Barreiro E, Gea J, Corominas JM, Hussain SN. Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2003;29:771-778. (Pubitemid 38045945)
22. Jang CW, Chen CH, Chen CC, Chen JY, Su YH, Chen RH. TGF-beta induces apoptosis through Smad-mediated expression of DAP-kinase. Nat Cell Biol 2002;4:51-58.
23. Alebiosu CO. An update on 'progression promoters' in renal diseases. J Natl Med Assoc 2003;95:30-42.
24. Agarwal R. Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy. BMC Nephrol 2005;6:13. (Pubitemid 41759734)
25. Jaimes EA, Tian RX, Raij L. Nicotine: the link between cigarette smoking and the progression of renal injury? Am J Physiol Heart Circ Physiol 2007;292:H76-H82.
26. Malfertheiner P, Schutte K. Smoking - a trigger for chronic inflammation and cancer development in the pancreas. Am J Gastroenterol 2006;101:160-162. (Pubitemid 43381724)
27. Wittel UA, Pandey KK, Andrianifahanana M, Johansson SL, Cullen DM, Akhter MP, et al. Chronic pancreatic inflammation induced by environmental tobacco smoke inhalation in rats. Am J Gastroenterol 2006;101:148-159. (Pubitemid 43381723)
28. Wright JL, Churg A. A model of tobacco smoke-induced airflow obstruction in the guinea pig. Chest 2002;121(5 Suppl):188S-191S. (Pubitemid 34497338)
29. Ardite E, Peinado VI, Rabinovich RA, Fernández-Checa JC, Roca J, Barberà JA. Systemic effects of cigarette smoke exposure in the guinea pig. Respir Med 2006;100:1186-1194. (Pubitemid 44207849)
30. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 2008;87:801-809. (Pubitemid 351549222)
31. Sastre J, Pallardo FV, Llopis J, Furukawa T, Vina JR, Vina J. Glutathione depletion by hyperphagia-induced obesity. Life Sci 1989;45:183-187.
32. Strauss RS, Barlow SE, Dietz WH. Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 2000;136:727-733.
33. Lirussi F, Azzalini L, Orando S, Orlando R, Angelico F. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev 2007;24:CD004996. (Pubitemid 351820394)
34. Bujanda L, Hijona E, Larzabal M, Beraza M, Aldazabal P, Garcia-Urkia N, et al. Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol 2008;8:40.
35. Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. HEPATOLOGY 2006;44:27-33.
36. Bataller R, Gabele E, Schoonhoven R, Morris T, Lehnert M, Yang L, et al. Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver. Am J Physiol Gastrointest Liver Physiol 2003;285:G642-G651. (Pubitemid 37021824)
37. Marra F, Arrighi MC, Fazi M, Caligiuri A, Pinzani M, Romanelli RG, et al. Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. HEPATOLOGY 1999;30:951-958. (Pubitemid 29458284)
38. Ladu S, Calvisi DF, Conner EA, Farina M, Factor VM, Thorgeirsson SS. E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer. Gastroenterology 2008;135:1322-1332.
39. Arredondo J, Chernyavsky AI, Jolkovsky DL, Pinkerton KE, Grando SA. Receptor-mediated tobacco toxicity: acceleration of sequential expression of alpha5 and alpha7 nicotinic receptor subunits in oral keratinocytes exposed to cigarette smoke. FASEB J 2008;22:1356-1368. (Pubitemid 351656777)
40. Lam DC, Girard L, Ramirez R, Chau WS, Suen WS, Sheridan S, et al. Expression of nicotinic acetylcholine receptor subunit genes in non-small-cell lung cancer reveals differences between smokers and nonsmokers. Cancer Res 2007;67:4638-4647. (Pubitemid 46910168)
41. Barbieri SS, Weksler BB. Tobacco smoke cooperates with interleukin-1beta to alter beta-catenin trafficking in vascular endothelium resulting in increased permeability and induction of cyclooxygenase-2 expression in vitro and in vivo. FASEB J 2007;21:1831-1843.
42. Bozinovski S, Vlahos R, Hansen M, Liu K, Anderson GP. Akt in the pathogenesis of COPD. Int J Chron Obstruct Pulmon Dis 2006;1:31-38.